Advertisement
COR vs MCK
Which Stock Would AI Choose? Cencora (COR) vs. McKesson (MCK) Stock Comparison
Key Takeaways
- Cencora (COR) and McKesson (MCK) operate in the pharmaceutical distribution and healthcare services sector, with both companies benefiting from steady demand for drug distribution and specialty services.
- Over recent weeks, MCK has demonstrated stronger price momentum, posting gains of approximately 11-12% in the past month compared to more modest or negative movements in COR.
- MCK reported robust fiscal 2026 results with double-digit revenue and adjusted earnings per share growth, while both firms maintain solid long-term uptrends amid sector tailwinds.
- Key contrasts include MCK’s broader diversification into medical-surgical products and technology solutions versus COR’s emphasis on international operations and specialty logistics.
- Market sentiment favors both stocks for their defensive characteristics, though relative performance has tilted toward MCK in the current environment.
- Analyst attention remains high ahead of MCK’s upcoming quarterly earnings, with both companies exhibiting strong free cash flow generation supporting capital returns.
Introduction
This comparison examines Cencora (COR) and McKesson (MCK), two leading players in pharmaceutical wholesaling and healthcare supply chain management. The analysis focuses on recent market activity, business fundamentals, and relative positioning to assist institutional and retail investors evaluating exposure within the healthcare distribution space. Traders monitoring sector rotation or seeking defensive growth opportunities may find the head-to-head assessment particularly relevant for portfolio construction and risk assessment.
Cencora Overview and Recent Performance
Cencora, Inc. (COR) provides pharmaceutical distribution, specialty logistics, and consulting services across the United States and internationally. The company serves retail pharmacies, hospitals, and healthcare providers with a focus on high-value specialty medications. In recent market activity, COR shares have experienced more muted performance relative to peers, with year-to-date returns lagging broader sector gains amid evolving reimbursement dynamics and competitive pressures. Sentiment has been influenced by steady volume growth in specialty products offset by margin considerations in core distribution, resulting in a more measured price trajectory over recent weeks.
McKesson Overview and Recent Performance
McKesson Corporation (MCK) delivers pharmaceutical distribution, medical-surgical supplies, and technology-enabled services to healthcare providers worldwide. The company has reported strong fiscal 2026 results, including 12% full-year revenue growth and 18% adjusted earnings per share expansion, exceeding prior targets. Over recent weeks, MCK shares have advanced approximately 11-12% in the past month, supported by consistent institutional accumulation and positive momentum ahead of its fiscal first-quarter earnings release. Broader market activity reflects sustained demand for its diversified offerings in oncology and biopharma services.
Trending AI Robots
Tickeron’s Trending AI Robots page highlights a curated selection of AI trading bots optimized for prevailing market conditions. Tickeron offers hundreds of AI Trading Bots capable of trading thousands of different tickers across equities, with each bot employing distinct trading styles, strategies, timeframes, performance metrics, and ticker sets. Only the highest-performing and most suitable bots for current environments earn placement in this trending section, where users can review ranges of returns, win rates, drawdowns, and trade frequencies. The platform enables investors to explore automated strategies tailored to various risk tolerances and market regimes. Review the full selection at Trending AI Robots.
Head-to-Head Comparison
Cencora (COR) and McKesson (MCK) share core exposure to pharmaceutical distribution yet differ in scale and diversification. MCK maintains a larger market capitalization and broader revenue streams through its Medical-Surgical and technology segments, providing additional growth drivers beyond traditional drug wholesaling. COR emphasizes international reach and specialized logistics capabilities, offering geographic diversification that can mitigate domestic reimbursement risks. Recent momentum has favored MCK, with stronger price appreciation and robust free cash flow supporting share repurchases, while COR has shown comparatively steadier but less aggressive performance. Risk factors for both include regulatory changes in healthcare pricing and supply chain disruptions, though MCK’s operational breadth may provide a marginal buffer. Sector sentiment remains constructive for the group, with both exhibiting low correlation to cyclical economic swings.
Tickeron AI Verdict
Based on observable factors such as trend consistency, stability, catalysts, and relative positioning, Tickeron’s AI would currently assign a slight probabilistic edge to McKesson (MCK). The combination of stronger recent price momentum, demonstrated earnings momentum, and diversified revenue streams aligns more favorably with quantitative models favoring sustained relative strength. Cencora (COR) presents solid characteristics in specialty areas and international exposure, supporting a balanced view where both stocks remain attractive within their sector. The assessment reflects probabilistic outcomes derived from available data rather than definitive forecasts.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Disclaimers and LimitationsTo compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COR is a Hold and MCK is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
COR’s FA Score shows that 2 FA rating(s) are green whileMCK’s FA Score has 2 green FA rating(s).
- COR’s FA Score: 2 green, 3 red.
- MCK’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
COR’s TA Score shows that 2 TA indicator(s) are bullish while MCK’s TA Score has 2 bullish TA indicator(s).
- COR’s TA Score: 2 bullish, 6 bearish.
- MCK’s TA Score: 2 bullish, 6 bearish.
Price Growth
COR (@Medical Distributors) experienced а -4.62% price change this week, while MCK (@Medical Distributors) price change was -1.69% for the same time period.
The average weekly price growth across all stocks in the @Medical Distributors industry was -12.62%. For the same industry, the average monthly price growth was -13.83%, and the average quarterly price growth was -25.12%.
Reported Earning Dates
COR is expected to report earnings on Nov 11, 2026.
MCK is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Medical Distributors (-12.62% weekly)Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.
| COR | MCK | COR / MCK | |
| Capitalization | 59.2B | 99.9B | 59% |
| EBITDA | 5.03B | 7.18B | 70% |
| Gain YTD | -7.844 | 4.640 | -169% |
| P/E Ratio | 23.01 | 22.98 | 100% |
| Revenue | 329B | 403B | 82% |
| Total Cash | 2.18B | 3.98B | 55% |
| Total Debt | 12.4B | 8.61B | 144% |
COR | MCK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 64 | 71 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 76 Overvalued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 30 | 16 | |
SMR RATING 1..100 | 12 | 100 | |
PRICE GROWTH RATING 1..100 | 49 | 45 | |
P/E GROWTH RATING 1..100 | 75 | 64 | |
SEASONALITY SCORE 1..100 | 65 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MCK's Valuation (11) in the Medical Distributors industry is somewhat better than the same rating for COR (76) in the Real Estate Investment Trusts industry. This means that MCK’s stock grew somewhat faster than COR’s over the last 12 months.
MCK's Profit vs Risk Rating (16) in the Medical Distributors industry is in the same range as COR (30) in the Real Estate Investment Trusts industry. This means that MCK’s stock grew similarly to COR’s over the last 12 months.
COR's SMR Rating (12) in the Real Estate Investment Trusts industry is significantly better than the same rating for MCK (100) in the Medical Distributors industry. This means that COR’s stock grew significantly faster than MCK’s over the last 12 months.
MCK's Price Growth Rating (45) in the Medical Distributors industry is in the same range as COR (49) in the Real Estate Investment Trusts industry. This means that MCK’s stock grew similarly to COR’s over the last 12 months.
MCK's P/E Growth Rating (64) in the Medical Distributors industry is in the same range as COR (75) in the Real Estate Investment Trusts industry. This means that MCK’s stock grew similarly to COR’s over the last 12 months.
| COR | MCK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 46% | 2 days ago 39% |
| Stochastic ODDS (%) | 2 days ago 48% | 2 days ago 33% |
| Momentum ODDS (%) | 2 days ago 41% | 2 days ago 41% |
| MACD ODDS (%) | 2 days ago 50% | 2 days ago 37% |
| TrendWeek ODDS (%) | 2 days ago 44% | 2 days ago 40% |
| TrendMonth ODDS (%) | 2 days ago 64% | 2 days ago 69% |
| Advances ODDS (%) | 4 days ago 61% | 4 days ago 66% |
| Declines ODDS (%) | 2 days ago 43% | 2 days ago 42% |
| BollingerBands ODDS (%) | 2 days ago 50% | 2 days ago 47% |
| Aroon ODDS (%) | 2 days ago 62% | 2 days ago 74% |
Advertisement
MCK and
Correlation & Price change
A.I.dvisor indicates that over the last year, MCK has been closely correlated with COR. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MCK jumps, then COR could also see price increases.
| Ticker / NAME | Correlation To MCK | 1D Price Change % | ||
|---|---|---|---|---|
| MCK | 100% | -2.51% | ||
| COR - MCK | 72% Closely correlated | -1.32% | ||
| CAH - MCK | 68% Closely correlated | -1.25% | ||
| HKPD - MCK | 10% Poorly correlated | +1.50% | ||
| HSIC - MCK | 6% Poorly correlated | -0.68% | ||
| YI - MCK | 4% Poorly correlated | -3.63% | ||
More | ||||